Copyright Reports & Markets. All rights reserved.

Global Immunohistochemistry (IHC) Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Immunohistochemistry (IHC) Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Immunohistochemistry (IHC) Testing by Type
    • 1.3.1 Overview: Global Immunohistochemistry (IHC) Testing Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Immunohistochemistry (IHC) Testing Consumption Value Market Share by Type in 2022
    • 1.3.3 Traditional Direct Method
    • 1.3.4 New Direct Method
    • 1.3.5 Enzyme Bridgemethod
    • 1.3.6 PAP Method
  • 1.4 Global Immunohistochemistry (IHC) Testing Market by Application
    • 1.4.1 Overview: Global Immunohistochemistry (IHC) Testing Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Research Institute
    • 1.4.4 Corporation
    • 1.4.5 Other
  • 1.5 Global Immunohistochemistry (IHC) Testing Market Size & Forecast
  • 1.6 Global Immunohistochemistry (IHC) Testing Market Size and Forecast by Region
    • 1.6.1 Global Immunohistochemistry (IHC) Testing Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Immunohistochemistry (IHC) Testing Market Size by Region, (2018-2029)
    • 1.6.3 North America Immunohistochemistry (IHC) Testing Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Immunohistochemistry (IHC) Testing Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size and Prospect (2018-2029)
    • 1.6.6 South America Immunohistochemistry (IHC) Testing Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Immunohistochemistry (IHC) Testing Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 University of Texas MD Anderson Cancer Center
    • 2.1.1 University of Texas MD Anderson Cancer Center Details
    • 2.1.2 University of Texas MD Anderson Cancer Center Major Business
    • 2.1.3 University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.1.4 University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 University of Texas MD Anderson Cancer Center Recent Developments and Future Plans
  • 2.2 Memorial Sloan Kettering Cancer Center
    • 2.2.1 Memorial Sloan Kettering Cancer Center Details
    • 2.2.2 Memorial Sloan Kettering Cancer Center Major Business
    • 2.2.3 Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.2.4 Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Memorial Sloan Kettering Cancer Center Recent Developments and Future Plans
  • 2.3 Mayo Clinic
    • 2.3.1 Mayo Clinic Details
    • 2.3.2 Mayo Clinic Major Business
    • 2.3.3 Mayo Clinic Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.3.4 Mayo Clinic Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Mayo Clinic Recent Developments and Future Plans
  • 2.4 Johns Hopkins Hospital
    • 2.4.1 Johns Hopkins Hospital Details
    • 2.4.2 Johns Hopkins Hospital Major Business
    • 2.4.3 Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.4.4 Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Johns Hopkins Hospital Recent Developments and Future Plans
  • 2.5 Cleveland Clinic
    • 2.5.1 Cleveland Clinic Details
    • 2.5.2 Cleveland Clinic Major Business
    • 2.5.3 Cleveland Clinic Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.5.4 Cleveland Clinic Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Cleveland Clinic Recent Developments and Future Plans
  • 2.6 Dana-Farber/Brigham and Women's Cancer Center
    • 2.6.1 Dana-Farber/Brigham and Women's Cancer Center Details
    • 2.6.2 Dana-Farber/Brigham and Women's Cancer Center Major Business
    • 2.6.3 Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.6.4 Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Dana-Farber/Brigham and Women's Cancer Center Recent Developments and Future Plans
  • 2.7 Cedars-Sinai Medical Center
    • 2.7.1 Cedars-Sinai Medical Center Details
    • 2.7.2 Cedars-Sinai Medical Center Major Business
    • 2.7.3 Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.7.4 Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Cedars-Sinai Medical Center Recent Developments and Future Plans
  • 2.8 Northwestern Memorial Hospital
    • 2.8.1 Northwestern Memorial Hospital Details
    • 2.8.2 Northwestern Memorial Hospital Major Business
    • 2.8.3 Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.8.4 Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Northwestern Memorial Hospital Recent Developments and Future Plans
  • 2.9 Seattle Cancer Care Alliance/University of Washington Medical Center
    • 2.9.1 Seattle Cancer Care Alliance/University of Washington Medical Center Details
    • 2.9.2 Seattle Cancer Care Alliance/University of Washington Medical Center Major Business
    • 2.9.3 Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.9.4 Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Seattle Cancer Care Alliance/University of Washington Medical Center Recent Developments and Future Plans
  • 2.10 University of California San Francisco Medical Center
    • 2.10.1 University of California San Francisco Medical Center Details
    • 2.10.2 University of California San Francisco Medical Center Major Business
    • 2.10.3 University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.10.4 University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 University of California San Francisco Medical Center Recent Developments and Future Plans
  • 2.11 CancerResearchUK
    • 2.11.1 CancerResearchUK Details
    • 2.11.2 CancerResearchUK Major Business
    • 2.11.3 CancerResearchUK Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.11.4 CancerResearchUK Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 CancerResearchUK Recent Developments and Future Plans
  • 2.12 Pfizer
    • 2.12.1 Pfizer Details
    • 2.12.2 Pfizer Major Business
    • 2.12.3 Pfizer Immunohistochemistry (IHC) Testing Product and Solutions
    • 2.12.4 Pfizer Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Pfizer Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Immunohistochemistry (IHC) Testing Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Immunohistochemistry (IHC) Testing by Company Revenue
    • 3.2.2 Top 3 Immunohistochemistry (IHC) Testing Players Market Share in 2022
    • 3.2.3 Top 6 Immunohistochemistry (IHC) Testing Players Market Share in 2022
  • 3.3 Immunohistochemistry (IHC) Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Immunohistochemistry (IHC) Testing Market: Region Footprint
    • 3.3.2 Immunohistochemistry (IHC) Testing Market: Company Product Type Footprint
    • 3.3.3 Immunohistochemistry (IHC) Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Immunohistochemistry (IHC) Testing Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Immunohistochemistry (IHC) Testing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Immunohistochemistry (IHC) Testing Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Immunohistochemistry (IHC) Testing Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Immunohistochemistry (IHC) Testing Consumption Value by Type (2018-2029)
  • 6.2 North America Immunohistochemistry (IHC) Testing Consumption Value by Application (2018-2029)
  • 6.3 North America Immunohistochemistry (IHC) Testing Market Size by Country
    • 6.3.1 North America Immunohistochemistry (IHC) Testing Consumption Value by Country (2018-2029)
    • 6.3.2 United States Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Immunohistochemistry (IHC) Testing Consumption Value by Type (2018-2029)
  • 7.2 Europe Immunohistochemistry (IHC) Testing Consumption Value by Application (2018-2029)
  • 7.3 Europe Immunohistochemistry (IHC) Testing Market Size by Country
    • 7.3.1 Europe Immunohistochemistry (IHC) Testing Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 7.3.3 France Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Immunohistochemistry (IHC) Testing Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Immunohistochemistry (IHC) Testing Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region
    • 8.3.1 Asia-Pacific Immunohistochemistry (IHC) Testing Consumption Value by Region (2018-2029)
    • 8.3.2 China Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 8.3.5 India Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Immunohistochemistry (IHC) Testing Consumption Value by Type (2018-2029)
  • 9.2 South America Immunohistochemistry (IHC) Testing Consumption Value by Application (2018-2029)
  • 9.3 South America Immunohistochemistry (IHC) Testing Market Size by Country
    • 9.3.1 South America Immunohistochemistry (IHC) Testing Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Immunohistochemistry (IHC) Testing Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Immunohistochemistry (IHC) Testing Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country
    • 10.3.1 Middle East & Africa Immunohistochemistry (IHC) Testing Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Immunohistochemistry (IHC) Testing Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Immunohistochemistry (IHC) Testing Market Drivers
  • 11.2 Immunohistochemistry (IHC) Testing Market Restraints
  • 11.3 Immunohistochemistry (IHC) Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Immunohistochemistry (IHC) Testing Industry Chain
  • 12.2 Immunohistochemistry (IHC) Testing Upstream Analysis
  • 12.3 Immunohistochemistry (IHC) Testing Midstream Analysis
  • 12.4 Immunohistochemistry (IHC) Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Immunohistochemistry (IHC) Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Immunohistochemistry (IHC) Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Immunohistochemistry (IHC) Testing market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Immunohistochemistry (IHC) Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Immunohistochemistry (IHC) Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Immunohistochemistry (IHC) Testing market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Immunohistochemistry (IHC) Testing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Immunohistochemistry (IHC) Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Mayo Clinic, Johns Hopkins Hospital and Cleveland Clinic, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Immunohistochemistry (IHC) Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Traditional Direct Method
    New Direct Method
    Enzyme Bridgemethod
    PAP Method
    Market segment by Application
    Hospital
    Research Institute
    Corporation
    Other
    Market segment by players, this report covers
    University of Texas MD Anderson Cancer Center
    Memorial Sloan Kettering Cancer Center
    Mayo Clinic
    Johns Hopkins Hospital
    Cleveland Clinic
    Dana-Farber/Brigham and Women's Cancer Center
    Cedars-Sinai Medical Center
    Northwestern Memorial Hospital
    Seattle Cancer Care Alliance/University of Washington Medical Center
    University of California San Francisco Medical Center
    CancerResearchUK
    Pfizer
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Immunohistochemistry (IHC) Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Immunohistochemistry (IHC) Testing, with revenue, gross margin and global market share of Immunohistochemistry (IHC) Testing from 2018 to 2023.
    Chapter 3, the Immunohistochemistry (IHC) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Immunohistochemistry (IHC) Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Immunohistochemistry (IHC) Testing.
    Chapter 13, to describe Immunohistochemistry (IHC) Testing research findings and conclusion.

    Buy now